Search Results - "Mira, José A."

Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus by Pineda, Juan A., Caruz, Antonio, Rivero, Antonio, Neukam, Karin, Salas, Irene, Camacho, Ángela, José C., Palomares, Mira, José A., Martínez, Antonio, Roldán, Carmen, de la Torre, Julián, Macías, Juan

“…Background. Variation in the IL28B gene is associated with sustained virologic response (SVR) to pegylated interferon plus ribavirin in hepatitis C virus…”
Get full text

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors by Rivero, Antonio, Mira, José A., Pineda, Juan A.

“…Liver toxicity is one of the most relevant adverse effects of antiretroviral therapy. Within the non-nucleoside reverse transcriptase inhibitors (NNRTIs),…”
Get full text

Incidence of and Risk Factors for Symptomatic Visceral Leishmaniasis among Human Immunodeficiency Virus Type 1-Infected Patients from Spain in the Era of Highly Active Antiretroviral Therapy by DE LA ROSA, Rafael, PINEDA, Juan A, DELGADO, Juan, MACIAS, Juan, MORILLAS, Francisco, MIRA, José A, SANCHEZ-QUIJANO, Armando, LEAL, Manuel, LISSEN, Eduardo

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir by Pineda, Juan A., Palacios, Rosario, Rivero, Antonio, Abdel-kader, Laila, Márquez, Manuel, Cano, Pilar, Mira, José A., Torre-Cisneros, Julián, Lozano, Fernando, Santos, Jesús

Get full text

Increased Hepatocyte Fas Expression and Apoptosis in HIV and Hepatitis C Virus Coinfection by Macías, Juan , Japón, Miguel A. , Sáez, Carmen , Palacios, Rosa B. , Mira, José A. , García‐García, José A. , Merchante, Nicolás , Vergara, Salvador , Lozano, Fernando , Gómez‐Mateos, Jesús , Pineda, Juan A. 

“…Background. Chronic hepatitis C disease (CHC) follows an accelerated course in human immunodeficiency virus (HIV) coinfection. The reasons for this are…”
Get full text

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus by Macías, Juan, Berenguer, Juan, Japón, Miguel A., Girón, José A., Rivero, Antonio, López‐Cortés, Luis F., Moreno, Ana, González‐Serrano, Mercedes, Iribarren, José A., Ortega, Enrique, Miralles, Pilar, Mira, José A., Pineda, Juan A.

“…A few studies have assessed the observed fibrosis progression between serial liver biopsies (LB) in human immunodeficiency virus (HIV) / hepatitis C virus…”
Get full text

Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19 by García-García, José A, Pérez-Quintana, Marta, Ramos-Giráldez, Consuelo, Cebrián-González, Isabel, Martín-Ponce, María L, del Valle-Villagrán, José, Navarro-Puerto, María A, Sánchez-Villegas, Jorge, Gómez-Herreros, Rocío, Manoja-Bustos, Isabel, León-Martí, Daniel, Serrano-Rodríguez, Lucía, de Miguel-Albarreal, Alejandra, Velasco-Romero, María J, Mula-Falcón, Francisco, Fernández-Pérez, Pilar, Melguizo-Moya, Isabel, Pérez-Quintana, María J, Romero-Molina, Guillermo, Vergara-López, Salvador, Marenco-de la Fuente, José L, Marín-Martín, Jorge, Mira-Escarti, José A

“…Background: Immunomodulatory drugs have been used in patients with severe COVID-19. The objective of this study was to evaluate the effects of two different…”
Get full text

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus—Coinfected Patients With Compensated Cirrhosis by Mira, José A., Rivero-Juárez, Antonio, López-Cortés, Luis F., Girón-González, José A., Téllez, Francisco, de Ios Santos-Gil, Ignacio, Macías, Juan, Merino, Dolores, Márquez, Manuel, Ríos-Villegas, María J., Gea, Isabel, Merchante, Nicolás, Rivero, Antonio, Torres-Cornejo, Almudena, Pineda, Juan A.

“…Background. The objective of this study was to determine the impact of sustained virologic response (SVR) to pegylated interferon (peg-IFN) plus ribavirin…”
Get full text

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort by Neukam, Karin, Mira, José A, Collado, Antonio, Rivero-Juárez, Antonio, Monje-Agudo, Patricia, Ruiz-Morales, Josefa, Ríos, María José, Merino, Dolores, Téllez, Francisco, Pérez-Camacho, Inés, Gálvez-Contreras, María Carmen, Rivero, Antonio, Pineda, Juan A

“…To assess the current frequency of ART-associated grade 3-4 transaminase elevations (TE) and grade 4 total bilirubin elevations (TBE) in HIV-infected patients…”
Get full text

Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography by Recio, Eva, Cifuentes, Celia, Macías, Juan, Mira, José A, Parra-Sánchez, Manuel, Rivero-Juárez, Antonio, Almeida, Carmen, Pineda, Juan A, Neukam, Karin

“…BACKGROUNDThe combination of transient elastometry with a controlled attenuation parameter (CAP) is available to evaluate hepatic steatosis (HS) along with…”
Get full text

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine by MACIAS, Juan, CASTELLANO, Victor, MERCHANTE, Nicolas, PALACIOS, Rosa B, MIRA, José A, SAEZ, Carmen, GARCIA-GARCIA, José A, LOZANO, Fernando, GOMEZ-MATEOS, Jesus M, PINEDA, Juan A

“…The hepatotoxicity of highly active antiretroviral therapy (HAART) could enhance liver fibrosis in HIV/Hepatitis C virus (HCV)-coinfected patients. Moreover,…”
Get full text

High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack by Macías, Juan, Palacios, Rosa B., Claro, Evangelina, Vargas, Julio, Vergara, Salvador, Mira, José A., Merchante, Nicolás, Corzo, Juan E., Pineda, Juan A.

“…Background: Most of the prevalent cases of hepatitis C virus (HCV) infection are attributable to intravenous drug using. However, a substantial number of…”
Get full text

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response by Neukam, Karin, Barreiro, Pablo, Rivero-Juárez, Antonio, Caruz, Antonio, Mira, José A, Camacho, Angela, Macías, Juan, Rivero, Antonio, Soriano, Vicente, Pineda, Juan A

“…Summary Objective Some experts consider that hepatitis C virus (HCV) genotype 1-infected patients harboring IL28B genotype CC should be treated with interferon…”
Get full text

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone by Mira, José A., López-Cortés, Luis F., Barreiro, Pablo, Tural, Cristina, Torres-Tortosa, Manuel, de los Santos Gil, Ignacio, Martín-Rico, Patricia, Ríos-Villegas, María J., Hernández-Burruezo, José Juan, Merino, Dolores, López-Ruz, Miguel Ángel, Rivero, Antonio, Muñoz, Leopoldo, González-Serrano, Mercedes, Collado, Antonio, Macías, Juan, Viciana, Pompeyo, Soriano, Vincent, Pineda, Juan A.

“…Objectives To compare the response to hepatitis C virus (HCV) therapy among human immunodeficiency virus (HIV)/HCV co-infected patients receiving a…”
Get full text

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin by Macías, Juan, del Valle, José, Rivero, Antonio, Mira, José A., Camacho, Ángela, Merchante, Nicolás, Pérez-Camacho, Inés, Neukam, Karin, Rivero-Juárez, Antonio, Mata, Rosario, Torre-Cisneros, Julián, Pineda, Juan A.

“…Objectives To evaluate the changes in liver stiffness measurement (LSM) in patients infected by hepatitis C virus (HCV) under pegylated interferon (Peg-IFN)…”
Get full text

Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves by Di Lello, Federico A., Neukam, Karin, Parra-Sanchez, Manuel, Plaza, Zulema, Soriano, Vicente, Cifuentes, Celia, Mira, José A., Poveda, Eva, Pineda, Juan A.

“…Hepatitis C virus genotype 4 (HCV‐4) is highly prevalent in Spain, but the information on the molecular characterization of HCV‐4 in this region is scarce. Due…”
Get full text

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus–Coinfected Patients With Compensated Liver Cirrhosis by Mira, José A., García-Rey, Silvia, Rivero, Antonio, de los Santos-Gil, Ignacio, López-Cortés, Luis F., Girón-González, José A., Téllez, Francisco, Márquez, Manuel, Merino, Dolores, Ríos-Villegas, María J., Macías, Juan, Rivero-Juárez, Antonio, Pineda, Juan A.

“…Background. The objective of this study was to determine the efficacy of pegylated interferon (peg-IFN) plus ribavirin (RBV) in human immunodeficiency virus…”
Get full text

Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort by Mancebo, María, Real, Luis M, Mira, José A, Recio, Eva, Pérez, Elisabet, Monje-Agudo, Patricia, Merchante, Nicolás, Macías, Juan, Neukam, Karin, Pineda, Juan A

“…BACKGROUNDThe drug options and strategies for treatment against hepatitis C virus (HCV) infection have changed considerably in the last few years. The aim of…”
Get full text

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers by Real, Luis M., Caruz, Antonio, Rivero-Juarez, Antonio, Soriano, Vicente, Neukam, Karin, Rivero, Antonio, Cifuentes, Celia, Mira, José A., Macías, Juan, Pineda, Juan A.

“…Background & Aims Host genetic factors could play a primary role in determining risk for cirrhosis development in HCV‐infected patients. The aims of this study…”
Get full text

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients by Neukam, Karin, Mira, José A., Ruiz-Morales, Josefa, Rivero, Antonio, Collado, Antonio, Torres-Cornejo, Almudena, Merino, Dolores, de los Santos-Gil, Ignacio, Macías, Juan, González-Serrano, Mercedes, Camacho, Angela, Parra-García, Ginés, Pineda, Juan A.

“…Objectives To compare the frequency of grade 3 or 4 transaminase elevations (TEs) in HIV/hepatitis C virus (HCV) co-infected patients who started a…”
Get full text